| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics, Inc. (VYGR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.1K | $2.01M | - | |
| COO | 199.7K | $830.9K | - | |
| Other | 183.9K | $765.1K | - | |
| CFO | 151.4K | $629.9K | - | |
| Other | 145.7K | $606.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | Swartz Robin69 | COO&Cbo | Sell | 6,500 | $5.65 | $36,725.00 | -5.5% | -31.8% | -30.4% | |
| Oct 2, 2024 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell | 5,999 | $5.82 | $34,914.18 | -6.5% | -2.6% | -18.9% | |
| Apr 2, 2024 | Swartz Robin69 | Chief Operating Officer | Sell | 1,357 | $9.88 | $13,407.16 | -1.1% | -20.7% | -65.6% | |
| Apr 2, 2024 | Sandrock Alfred67 | President And CEO | Sell | 12,115 | $9.86 | $119,453.90 | -3.6% | -20.7% | -65.6% | |
| Feb 21, 2024 | Swartz Robin69 | Chief Operating Officer | Sell | 3,966 | $7.45 | $29,546.70 | -3.2% | +10.5% | -44.2% | |
| Feb 21, 2024 | Sandrock Alfred67 | President And CEO | Sell | 13,033 | $7.46 | $97,226.18 | -3.7% | +10.5% | -44.2% | |
| Feb 21, 2024 | Pfreundschuh Peter P.82 | Chief Financial Officer | Sell | 3,764 | $7.46 | $28,079.44 | -2.1% | +10.5% | -44.2% | |
| Feb 21, 2024 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 3,967 | $7.50 | $29,759.91 | -2.2% | +10.5% | -44.2% | |
| Jan 17, 2024 | Swartz Robin69 | Chief Operating Officer | Sell | 2,543 | $7.15 | $18,182.45 | -3.4% | +9.3% | -30.7% | |
| Jan 17, 2024 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 1,266 | $7.18 | $9,089.88 | -2.3% | +9.3% | -30.7% |